Probiotic Limosilactobacillus reuteri DSM 17938 Changes Foxp3 Deficiency-Induced Dyslipidemia and Chronic Hepatitis in Mice

E Nessim Kostandy, JH Suh, X Tian, B Okeugo… - Nutrients, 2024 - mdpi.com
The probiotic Limosilactobacillus reuteri DSM 17938 produces anti-inflammatory effects in
scurfy (SF) mice, a model characterized by immune dysregulation, polyendocrinopathy …

Limosilactobacillus reuteri and Lacticaseibacillus rhamnosus GG differentially affect gut microbes and metabolites in mice with Treg deficiency

Y Liu, TK Hoang, CM Taylor, ES Park… - American Journal …, 2021 - journals.physiology.org
Treg deficiency causes a lethal, CD4+ T cell-driven autoimmune disease called IPEX
syndrome (immunodysregulation, polyendocrinopathy, and enteropathy, with X-linked …

Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese mice

B Kim, KY Park, Y Ji, S Park, W Holzapfel… - … and biophysical research …, 2016 - Elsevier
Recent reports suggest that gut microbiota can be a major determinant of dyslipidemia and
non-alcoholic fatty liver disease (NAFLD) and its modulation by treating probiotics is a valid …

Immunobiotics beneficially modulate TLR4 signaling triggered by lipopolysaccharide and reduce hepatic steatosis in vitro

P Kanmani, AZ Ansari, J Villena… - Journal of immunology …, 2019 - Wiley Online Library
Hepatic inflammation and injury may result from the translocation of pathological bacteria
and their proinflammatory mediators. Probiotics attenuate hepatic diseases related to …

[PDF][PDF] VSL# 3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet‐induced nonalcoholic steatohepatitis model in mice

A Velayudham, A Dolganiuc, M Ellis, J Petrasek… - …, 2009 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) and its advanced stage, nonalcoholic
steatohepatitis (NASH), are the most common causes of chronic liver disease in the United …

[HTML][HTML] Antibiotic-modulated microbiome suppresses lethal inflammation and prolongs lifespan in Treg-deficient mice

B He, Y Liu, TK Hoang, X Tian, CM Taylor, M Luo… - Microbiome, 2019 - Springer
Abstract Background Regulatory T cell (Treg) deficiency leads to IPEX syndrome, a lethal
autoimmune disease, in Human and mice. Dysbiosis of the gut microbiota in Treg-deficient …

Inhibition of intestinal FXR activity as a possible mechanism for the beneficial effects of a probiotic mix supplementation on lipid metabolism alterations and weight …

A Beau, B Benoit, M Le Barz, E Meugnier… - Gut …, 2023 - Taylor & Francis
Supplementation with probiotics has emerged as a promising therapeutic tool to manage
metabolic diseases. We investigated the effects of a mix of Bifidobacterium animalis subsp …

Immunobiotic Bacteria Attenuate Hepatic Fibrosis through the Modulation of Gut Microbiota and the Activation of Aryl‐Hydrocarbon Receptors Pathway in Non …

P Kanmani, J Villena, S Lim, EJ Song… - Molecular Nutrition & …, 2024 - Wiley Online Library
Scope Nonalcoholic steatohepatitis (NASH) is a leading cause of chronic liver disease
worldwide that can progress to liver fibrosis (LF). Probiotics have beneficial roles in reducing …

[HTML][HTML] Dual probiotic strains suppress high fructose-induced metabolic syndrome

DY Park, YT Ahn, CS Huh, RA McGregor… - World Journal of …, 2013 - ncbi.nlm.nih.gov
AIM: To investigate the effect of novel probiotics on the clinical characteristics of high-
fructose induced metabolic syndrome. METHODS: Male Wistar rats aged 4 wk were fed a …

Probiotic yogurt regulates gut microbiota homeostasis and alleviates hepatic steatosis and liver injury induced by high‐fat diet in golden hamsters

L Zhu, N Ying, L Hao, A Fu, Q Ding, F Cao… - Food Science & …, 2024 - Wiley Online Library
This study aimed to investigate the beneficial effects of probiotic yogurt on lipid metabolism
and gut microbiota in metabolic‐related fatty liver disease (MAFLD) golden hamsters fed on …